Literature DB >> 21979434

Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.

Suguru Yamamoto1, Patricia G Yancey, Yiqin Zuo, Li-Jun Ma, Ryohei Kaseda, Agnes B Fogo, Iekuni Ichikawa, MacRae F Linton, Sergio Fazio, Valentina Kon.   

Abstract

OBJECTIVE: Angiotensin II is a major determinant of atherosclerosis. Although macrophages are the most abundant cells in atherosclerotic plaques and express angiotensin II type 1 receptor (AT1), the pathophysiologic role of macrophage AT1 in atherogenesis remains uncertain. We examined the contribution of macrophage AT1 to accelerated atherosclerosis in an angiotensin II-responsive setting induced by uninephrectomy (UNx). METHODS AND
RESULTS: AT1(-/-) or AT1(+/+) marrow from apolipoprotein E deficient (apoE(-/-)) mice was transplanted into recipient apoE(-/-) mice with subsequent UNx or sham operation: apoE(-/-)/AT1(+/+)→apoE(-/-)+sham; apoE(-/-)/AT1(+/+) →apoE(-/-)+UNx; apoE(-/-)/AT1(-/-)→apoE(-/-)+sham; apoE(-/-)/AT1(-/-)→apoE(-/-)+UNx. No differences in body weight, blood pressure, lipid profile, and serum creatinine were observed between the 2 UNx groups. ApoE(-/-)/AT1(+/+) →apoE(-/-)+UNx had significantly more atherosclerosis (16907±21473 versus 116071±8180 μm(2), P<0.05). By contrast, loss of macrophage AT1 which reduced local AT1 expression, prevented any effect of UNx on atherosclerosis (77174±9947 versus 75714±11333 μm(2), P=NS). Although UNx did not affect total macrophage content in the atheroma, lesions in apoE(-/-)/AT1(-/-)→apoE(-/-)+UNx had fewer classically activated macrophage phenotype (M1) and more alternatively activated phenotype (M2). Further, UNx did not affect plaque necrosis or apoptosis in apoE(-/-)/AT1(-/-)→apoE(-/-) whereas it significantly increased both (by 2- and 6-fold, respectively) in apoE(-/-)/AT1(+/+) →apoE(-/-) mice. Instead, apoE(-/-)/AT1(-/-)→apoE(-/-) had 5-fold-increase in macrophage-associated apoptotic bodies, indicating enhanced efferocytosis. In vitro studies confirmed blunted susceptibility to apoptosis, especially in M2 macrophages, and a more efficient phagocytic function of AT1(-/-) macrophages versus AT1(+/+).
CONCLUSIONS: AT1 receptor of bone marrow-derived macrophages worsens the extent and complexity of renal injury-induced atherosclerosis by shifting the macrophage phenotype to more M1 and less M2 through mechanisms that include increased apoptosis and impaired efferocytosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979434      PMCID: PMC3227118          DOI: 10.1161/ATVBAHA.111.237198

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  51 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.

Authors:  Masashi Nishida; Hidehiko Fujinaka; Taiji Matsusaka; James Price; Valentina Kon; Agnes B Fogo; Jeffrey M Davidson; MacRae F Linton; Sergio Fazio; Toshio Homma; Hiroaki Yoshida; Iekuni Ichikawa
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.

Authors:  Jonathan E Feig; James X Rong; Raanan Shamir; Marie Sanson; Yuliya Vengrenyuk; Jianhua Liu; Katey Rayner; Kathryn Moore; Michael Garabedian; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

4.  Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.

Authors:  Li-Jun Ma; Bridgette A Corsa; Jun Zhou; HaiChun Yang; HaiJing Li; Yi-Wei Tang; Vladimir R Babaev; Amy S Major; MacRae F Linton; Sergio Fazio; Tracy E Hunley; Valentina Kon; Agnes B Fogo
Journal:  Am J Physiol Renal Physiol       Date:  2011-03-02

5.  Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?

Authors:  Y Dörffel; S Franz; A Pruss; G Neumann; W Rohde; G R Burmester; J Scholze
Journal:  Atherosclerosis       Date:  2001-07       Impact factor: 5.162

6.  Circulating monocyte subpopulations with high expression of angiotensin-converting enzyme predict mortality in patients with end-stage renal disease.

Authors:  Christof Ulrich; Gunnar H Heine; Eric Seibert; Danilo Fliser; Matthias Girndt
Journal:  Nephrol Dial Transplant       Date:  2010-02-10       Impact factor: 5.992

7.  Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice.

Authors:  Guangwei Liu; Haixia Ma; Lin Qiu; Long Li; Yuhong Cao; Jun Ma; Yong Zhao
Journal:  Immunol Cell Biol       Date:  2010-06-01       Impact factor: 5.126

8.  Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.

Authors:  Suguru Yamamoto; Yiqin Zuo; Ji Ma; Patricia G Yancey; Tracy E Hunley; Masaru Motojima; Agnes B Fogo; Macrae F Linton; Sergio Fazio; Iekuni Ichikawa; Valentina Kon
Journal:  Nephrol Dial Transplant       Date:  2011-01-18       Impact factor: 5.992

9.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Authors:  S Fazio; A S Major; L L Swift; L A Gleaves; M Accad; M F Linton; R V Farese
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

10.  Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice.

Authors:  L Guo; R S Johnson; J C Schuh
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

View more
  52 in total

1.  Angiotensin IV is induced in experimental autoimmune encephalomyelitis but fails to influence the disease.

Authors:  Arndt Manzel; Oliver Domenig; Bjoern Ambrosius; Agnes Kovacs; Johannes Stegbauer; Marko Poglitsch; Dominik N Mueller; Ralf Gold; Ralf A Linker
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-23       Impact factor: 4.147

Review 2.  Interactions Between the Immune and the Renin-Angiotensin Systems in Hypertension.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

3.  Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone.

Authors:  Sun Wook Cho; Fabiana N Soki; Amy J Koh; Matthew R Eber; Payam Entezami; Serk In Park; Nico van Rooijen; Laurie K McCauley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-09       Impact factor: 11.205

4.  Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.

Authors:  Suguru Yamamoto; Jiayong Zhong; Patricia G Yancey; Yiqin Zuo; MacRae F Linton; Sergio Fazio; Haichun Yang; Ichiei Narita; Valentina Kon
Journal:  Atherosclerosis       Date:  2015-07-04       Impact factor: 5.162

Review 5.  Innate immunity in hypertension.

Authors:  Muhammad Oneeb Rehman Mian; Pierre Paradis; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

6.  Hypertensive urgencies and emergencies: Misconceptions and pitfalls.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Eur J Intern Med       Date:  2019-11-06       Impact factor: 4.487

7.  The Role of Efferocytosis in Atherosclerosis.

Authors:  Yoko Kojima; Irving L Weissman; Nicholas J Leeper
Journal:  Circulation       Date:  2017-01-31       Impact factor: 29.690

Review 8.  Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Authors:  Annamaria Mascolo; Konrad Urbanek; Antonella De Angelis; Maurizio Sessa; Cristina Scavone; Liberato Berrino; Giuseppe Massimo Claudio Rosano; Annalisa Capuano; Francesco Rossi
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

9.  Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice.

Authors:  Soichiro Tajima; Yasumasa Ikeda; Hideaki Enomoto; Mizuki Imao; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Licht Miyamoto; Keisuke Ishizawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Eur J Nutr       Date:  2014-08-07       Impact factor: 5.614

10.  Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.

Authors:  Mario Menk; Jan Adriaan Graw; Clarissa von Haefen; Marco Sifringer; David Schwaiberger; Thomas Unger; Ulrike Steckelings; Claudia D Spies
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.